Vitamin D Treatment for Painful Diabetic Neuropathy

NCT02737423 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 143

Last updated 2016-04-14

No results posted yet for this study

Summary

The main objective of the study is to assess the effect of vitamin D treatment on painful diabetic neuropathy in Pakistan.

This is a prospective study of diabetic patients with a DN score ≥ 4, administered a single dose of 600,000 IU of Vitamin D.

All diabetic patients (type 1 and type 2) at the screening visit were considered eligible to participate in the study. The change in painful diabetic neuropathy scores was assessed using DN4 Neuropathic Pain Diagnostic Questionnaire and SF - MPQ for all participants at each visit.

Conditions

  • Diabetic Neuropathy

Interventions

DRUG

cholecalciferol

Effect of Vitamin D on the symptoms of diabetic neuropathy

Sponsors & Collaborators

  • Baqai Institute of Diabetology and Endocrinology

    lead OTHER

Principal Investigators

  • Abdul Basit, MRCP · Baqai Institute of Diabetology and Endocrinology, Baqai Medical University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2013-06-30
Completion
2013-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02737423 on ClinicalTrials.gov